View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.
Ryan Littich is a Director in CAS’s Services group, and Sr. Innovation Portfolio Manager in CAS’s Innovation division. He is responsible for driving CAS’s strategy and offerings across the Life Sciences R&D informatics continuum, with an emphasis on drug discovery and preclinical process development. Before joining CAS, Ryan contributed to and led product and process R&D at a Fortune 500 specialty chemical manufacturer (AkzoNobel Surface Chemistry, LLC) and a venture capital-backed chemical startup (Elevance Renewable Sciences, Inc). Dr. Littich is a synthetic organic chemist by training, with a foundation in the de novo synthesis of medicinally relevant natural products. Ryan holds a Ph.D. in Synthetic Organic Chemistry from the University of Texas at Austin.